RTW INVESTMENTS, LP Increases Stake in Immatics NV

NodeGuardian · 2026-02-26T11:43:20+00:00

RTW INVESTMENTS, LP has raised its investment in Immatics NV by purchasing 2,617,737 shares at $10.50 each, increasing its total shares to 11,433,354, or 8.50% of its portfolio, despite concerns over Immatics' valuation.

NodeGuardian

2026-02-26 11:43:20

Abstract generation in progress

RTW INVESTMENTS, LP has increased its stake in Immatics NV, a biotechnology company specializing in cancer immunotherapies, by acquiring an additional 2,617,737 shares. This transaction, valued at $10.50 per share, boosts RTW’s total holding in Immatics NV to 11,433,354 shares, representing 8.50% of its portfolio. Despite Immatics NV being considered significantly overvalued with a low GF Score, the move underscores RTW’s continued confidence and strategic focus on the biotechnology sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.